Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Andrews, N. J, Waight, P. A, Burbidge, P., Pearce, E., Roalfe, L., Zancolli, M., Slack, M., Ladhani, S. N, Miller, E., & Goldblatt, D. The Lancet infectious diseases, 14(9):839–846, Elsevier, 2014.
bibtex   
@article{Andrewsetal2014,
  title={Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study},
  author={Andrews, Nick J and Waight, Pauline A and Burbidge, Polly and Pearce, Emma and Roalfe, Lucy and Zancolli, Marta and Slack, Mary and Ladhani, Shamez N and Miller, Elizabeth and Goldblatt, David},
  journal={The Lancet infectious diseases},
  volume={14},
  number={9},
  pages={839--846},
  year={2014},
  publisher={Elsevier}
}

Downloads: 0